Skip to content

Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate

C18H17FN4O6 — CID 118714073

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate
SMILESCCOC(=O)c1cn(CC(O)Cn2cnc([N+](=O)[O-])c2)c2c(F)cccc2c1=O
InChIInChI=1S/C18H17FN4O6/c1-2-29-18(26)13-8-22(16-12(17(13)25)4-3-5-14(16)19)7-11(24)6-21-9-15(20-10-21)23(27)28/h3-5,8-11,24H,2,6-7H2,1H3
InChIKeyZRWUHINQZNVKLH-UHFFFAOYSA-N
MW404.35 g/mol
LogP1.48
Rot. Bonds7

About Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate

Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate (PubChem CID 118714073) has the molecular formula C18H17FN4O6 and a molecular weight of 404.35 g/mol. Its IUPAC name is ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate.

Molecular Properties

Compound NameEthyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate
PubChem CID118714073
Molecular FormulaC18H17FN4O6
Molecular Weight404.35 g/mol
Exact Mass404.11
IUPAC Nameethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate
SMILESCCOC(=O)c1cn(CC(O)Cn2cnc([N+](=O)[O-])c2)c2c(F)cccc2c1=O
InChIInChI=1S/C18H17FN4O6/c1-2-29-18(26)13-8-22(16-12(17(13)25)4-3-5-14(16)19)7-11(24)6-21-9-15(20-10-21)23(27)28/h3-5,8-11,24H,2,6-7H2,1H3
InChIKeyZRWUHINQZNVKLH-UHFFFAOYSA-N
XLogP1.48
TPSA129.49 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500404.35
LogP ≤ 51.48
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate?
The IUPAC name of Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate (CID 118714073) is ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate.
What is the SMILES notation for Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate?
The canonical SMILES for Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate is CCOC(=O)c1cn(CC(O)Cn2cnc([N+](=O)[O-])c2)c2c(F)cccc2c1=O.
What is the InChIKey of Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate?
The InChIKey is ZRWUHINQZNVKLH-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H17FN4O6/c1-2-29-18(26)13-8-22(16-12(17(13)25)4-3-5-14(16)19)7-11(24)6-21-9-15(20-10-21)23(27)28/h3-5,8-11,24H,2,6-7H2,1H3.
What are the key properties of Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate?
Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate has a molecular weight of 404.35 g/mol, XLogP of 1.48, 7 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for Ethyl 8-fluoro-1-[2-hydroxy-3-(4-nitroimidazol-1-yl)propyl]-4-oxoquinoline-3-carboxylate is sourced from PubChem (CID 118714073), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.